Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00830557 · ClinicalTrials.gov registry record
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
A clinical trial of Pancreatic Cancer and Pancreatic Adenocarcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 3
- Study locations
NCT00830557 is a study of Pancreatic Cancer and Pancreatic Adenocarcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 20,000 participants, above the 321-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (6131% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT00830557, a study of Pancreatic Cancer and Pancreatic Adenocarcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future. PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.
Conditions Studied
Interventions
- OTHER medical chart review
- OTHER survey administration
- OTHER biospecimen collection
Study Locations (3)
Arizona
- Mayo Clinic Hospital in Arizona - Phoenix
Florida
- Mayo Clinic in Florida - Jacksonville
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2000-10-01 |
| Est. Completion | 2027-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00830557
The ClinicalTrials.gov registry entry for NCT00830557 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 321-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (6131% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Pancreatic Cancer appearing as the primary indexed condition, and to 3 interventions - of which medical chart review is the first listed.
NCT00830557 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT00830557 about?
NCT00830557 is a clinical study titled "Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders". RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future. PURPOSE: This clinical trial is collecting medic...
What is the current status of trial NCT00830557?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2000-10-01. Estimated completion is 2027-08-30.
What conditions does trial NCT00830557 study?
This clinical trial studies the following conditions: Pancreatic Cancer, Pancreatic Adenocarcinoma, Chronic Pancreatitis, Acute Pancreatitis, Pancreatic Disease.
What interventions are being tested in trial NCT00830557?
The interventions under investigation include: medical chart review (OTHER), survey administration (OTHER), biospecimen collection (OTHER).
Who is sponsoring clinical trial NCT00830557?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00830557 being conducted?
This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RECRUITING · Phase 1
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer
RECRUITING · Phase 1
-
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
RECRUITING · Phase 1
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.